Literature DB >> 1239240

[Pathomorphogenesis of blistering in epidermolysis bullosa acquisita and epidermolysis bullosa dystrophica (author's transl)].

J Metz, H Frank, G Metz.   

Abstract

Electronmicroscopical examination on skin lesions of epidermolysis bullosa dystrophica recessiva (E.b.d.r.) and epidermolysis bullosa acquisita (E.b.a.) associated with Crohn's disease have demonstrated that blistering occurs between epidermis and dermis beneath the basal lamina. The structural defect concerns the anchoring fibrils only which are missing in the junctional zone of the involved skin. All other junctional structures are intact. Beneath the basal lamina a band-like zone of a moderate electrondense, amorphous material is seen in the skin-lesions of epidermolysis bullosa acquisita, less marked in epidermolysis bullosa dystrophica. Direct immunofluorescent investigation of involved skin of E.b.a. shows a pemphigoid-like fluorescent pattern at the basal lamina with antihuman IgG-, -IgM-, beta1c/beta1a and antihuman C1q-component. In epidermolysis bullosa dystrophica, however, a fluorescent pattern at the basal lamina was found only with anti-human IgG and Anti-C3. The pathogenetic importance of the immunoglobuline-deposits at the basal lamina is discussed in regard of the loss of anchoring fibrils and the subsequent vesication in these types of epidermolytic diseases.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1239240     DOI: 10.1007/bf00561541

Source DB:  PubMed          Journal:  Arch Dermatol Res            Impact factor:   3.017


  17 in total

1.  [Acquired epidermolysis bullosa in Crohn's disease].

Authors:  G Metz; J Metz; H Frank
Journal:  Hautarzt       Date:  1975-06       Impact factor: 0.751

2.  Studies on the pathogenesis of epidermolysis bullosa.

Authors:  R W PEARSON
Journal:  J Invest Dermatol       Date:  1962-12       Impact factor: 8.551

3.  Epidermolysis bullosa acquisita with electron microscopical studies.

Authors:  R B Gibbs; H R Minus
Journal:  Arch Dermatol       Date:  1975-02

4.  Evidence for complement-binding immune complexes in adult coeliac disease, Crohn's disease, and ulcerative colitis.

Authors:  W F Doe; C C Booth; D L Brown
Journal:  Lancet       Date:  1973-02-24       Impact factor: 79.321

5.  Tissue antibodies in dermatitis herpetiformis and adult coeliac disease.

Authors:  P P Seah; L Fry; A V Hoffbrand; E J Holborow
Journal:  Lancet       Date:  1971-04-24       Impact factor: 79.321

6.  [Electron microscopical studies on allergic and toxic skin test reactions in humans].

Authors:  J Metz
Journal:  Arch Dermatol Forsch       Date:  1972

7.  [Epidermolysis bullosa dystrophica dominans-a defect of the anchoring fibrils? (authors transl)].

Authors:  I Anton-Lamprecht; U W Schnyder
Journal:  Dermatologica       Date:  1973

8.  Dermo-epidermal separation with suction. Electron microscopic and histochemical study of initial events of blistering on human skin.

Authors:  U Kiistala; K K Mustakallio
Journal:  J Invest Dermatol       Date:  1967-05       Impact factor: 8.551

9.  [Fine structure investigations in hereditary recessive dystrophic epidermolysis bullosa].

Authors:  A Vogel; U W Schnyder
Journal:  Dermatologica       Date:  1967

10.  Formation and origin of basal lamina and anchoring fibrils in adult human skin.

Authors:  R A Briggaman; F G Dalldorf; C E Wheeler
Journal:  J Cell Biol       Date:  1971-11       Impact factor: 10.539

View more
  2 in total

1.  Disseminated cicatricial pemphigoid in a child and in an adult. Ultrastructural diagnostic criteria and differential diagnosis with special reference to acquired epidermolysis bullosa.

Authors:  I Hausser; M Fartasch; E Schleiermacher; I Anton-Lamprecht
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

2.  Ultrastructural studies in epidermolysis bullosa hereditaria. III. Recessive dystrophic types with dermolytic blistering (Hallopeau-Siemens types and inverse type).

Authors:  I Hashimoto; U W Schnyder; I Anton-Lamprecht; T Gedde-Dahl; S Ward
Journal:  Arch Dermatol Res       Date:  1976-08-27       Impact factor: 3.017

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.